| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.11B | 4.99B | 5.99B | 6.62B | 7.05B | 7.18B |
| Gross Profit | 1.36B | 2.66B | 1.73B | 3.53B | 2.42B | 3.17B |
| EBITDA | 9.60B | 9.94B | 9.86B | 9.28B | 8.94B | 3.84B |
| Net Income | 8.15B | 8.12B | 8.03B | 7.75B | 7.51B | 7.32B |
Balance Sheet | ||||||
| Total Assets | 164.62B | 157.84B | 165.87B | 165.87B | 163.00B | 167.41B |
| Cash, Cash Equivalents and Short-Term Investments | 4.72B | 8.11B | 13.08B | 18.05B | 8.09B | 13.48B |
| Total Debt | 20.71B | 19.54B | 24.57B | 28.56B | 40.12B | 32.93B |
| Total Liabilities | 29.39B | 26.59B | 32.60B | 46.37B | 47.04B | 55.85B |
| Stockholders Equity | 135.16B | 131.16B | 133.18B | 119.39B | 115.83B | 111.44B |
Cash Flow | ||||||
| Free Cash Flow | 1.55B | 1.59B | 3.50B | 6.64B | 7.47B | 8.15B |
| Operating Cash Flow | 1.91B | 1.97B | 3.85B | 7.12B | 7.83B | 8.36B |
| Investing Cash Flow | 3.66B | 3.18B | 2.41B | 14.87B | -1.04B | 7.00B |
| Financing Cash Flow | -10.03B | -10.12B | -11.22B | -6.19B | -12.19B | -7.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$153.94B | 16.68 | 6.45% | 4.50% | -10.67% | 0.65% | |
72 Outperform | HK$187.84B | 16.48 | 9.82% | 4.54% | 2.02% | 51.27% | |
70 Outperform | HK$74.19B | 12.01 | 12.60% | 4.30% | -3.19% | -2.68% | |
68 Neutral | HK$97.54B | 6.06 | 12.76% | 5.89% | 1.42% | -10.32% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | HK$135.47B | 23.00 | 9.73% | 4.94% | 0.36% | 2.55% | |
62 Neutral | HK$135.01B | 18.85 | 6.94% | 5.15% | -24.63% | 1.74% |